Senile dementia of the Alzheimer type is accompanied by hypertrophy of galanin axons, reservation of receptors and tissue specific expression of the galanin gene in the nucleus basalis Meynert
The cholinergic neurons of the basal nucleus of Meynert (bnM) (Meynert, 1872) is a major source of cholinergic input to the cerebral cortex in animals and in man. It is now well established that cholinergic cells in the bnM undergo varying degrees of degenerative change with neuron loss in neurodegenerative diseases, such as senile dementia of the Alzheimer type (SDAT) (Davies and Maloney, 1976; Whitehouse et al., 1982; Wilcock et al., 1982; Bowen et al., 1983) and in Parkinson’s disease (Gaspar et al., 1984; Perry et al., 1985; Chan-Palay, 1988 a,b). Although it is clear that there are multiple factors affecting neurotransmitters in the Alzheimer brain, there is evidence that reduced cholinergic neurotransmission is related to the cognitive dysfunctions, including deficits in learning and memory (Mastropaolo et al., 1988). This association is certainly not a simple one but probably involves multiple chemical systems interacting with acetylcholine, such as galanin (Chan-Palay et al., 1990) or nerve groeth factor (Ernfors et al. 1990).
KeywordsDepression Ischemia Amidated Dementia Glycine
Unable to display preview. Download preview PDF.
- 1.Bonnefond, C., Mengod, G., Probst, A., Palacios, J.M. (1990). Distribution of galanin mRNA containing cells and galanin receptor binding sites in human and rat hypothalamus. Eur. J. Neurosci., (in press).Google Scholar
- 2.Bowen, D.M.; Benton, J.S.; Spillane, J.A.; Smith, C.C.T.; Allen, S.J. (1983). Choline acetyltransferase activity and histopathology of frontal neocortex biopsies of demented patients. J. Neurol. Sci., 57, 181–202.Google Scholar
- 4.Chan-Palay, V.b. (1988b). Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer’s and Parkinson’s disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol., 273, 543–557PubMedCrossRefGoogle Scholar
- 5.Chan-Palay, V.; Ernfors, P.; Perssoh, H.(1990). Senile dementia of the Alzheimer type is accompanied by an increase in tissue specific expression of galanin gene in the nucleus basalis Meynert. Dementia, 1, (in press)Google Scholar
- 7.Ernfors, P.; Lindefors, N.; Chan-Palay, V.; Persson, H. (1990). Cholinergic neurons of nucleus basalis express elevated levels of nerve growth factor mRNA in senile dementia of the Alzheimer type. Proc. Natl. Acad. Sci. USA, (in press).,Google Scholar
- 10.Köhler, C.; Chan-Palay, V. (1990). Preservation of Galanin receptors in the human basal nucleus of Meynert in senile dementia of the Alzheimer type. Dementia, 1, (In press)Google Scholar
- 14.Meynert, T. (1872). In Putnam JJ (Transl), A Manual of Histology, William Wood, New York, 650–766Google Scholar
- 15.Perry, E.K.; Curtis, M.; Dick, D.J.; Candy, J. M.; Atack, J.R.; Bloxham, C.A.; Blessed, G.; Fairbairn, A.F.; Tomlinson, B.E.; Perry, R.H. (1985). Cholinergic correlates of cognitive impairment in Parkinson’s disease: Comparison with Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry, 48, 413–421.PubMedPubMedCentralCrossRefGoogle Scholar
- 19.Whitehouse, P.J.; Price, D.I.; Struble, R. G.; Clark, A.W.; Coyle, J.T.; DeLong, M.R. (1982). Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 12 37–1239.Google Scholar